The global market for Bipolar Disorder Therapeutic was valued at US$ 4012 million in the year 2024 and is projected to reach a revised size of US$ 4607 million by 2031, growing at a CAGR of 2.0% during the forecast period.

Bipolar Disorder Therapeutic Market

Bipolar disorder, also known as manic-depressive disorder, is a mental illness. It is a mental health problem that primarily affects mood. Symptoms of bipolar disorder are extreme irritability or agitation, a period of feeling empty, loss of interest in normal activities, sleep problems, etc. According to Pfizer, Inc., bipolar disorder affects over 5 million people in the U.S. Bipolar episodes are characterized by a drastic change in behavior and mood, and range from joyful and overexcited (manic episodes) to extremely sad and hopeless (depressive state). These disorders have different types of episodes such as manic episodes, hypomanic episodes, depressive episodes, and mixed episodes. Causes of bipolar disorders include childhood trauma, stressful life events, self-esteem problems, and genetic inheritance. People across the world marked “March 30” as a World Bipolar Day to spread awareness about the disorder and erase the stigma of mental illness. Large number of people suffering from this mental condition resort to drinking to lift their mood. According to the National Institute on Alcohol Abuse and Alcoholism, 27.6% of the people with bipolar disorder become addicted to alcohol, while over 16% engaged in alcohol abuse.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bipolar Disorder Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bipolar Disorder Therapeutic.

The Bipolar Disorder Therapeutic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bipolar Disorder Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bipolar Disorder Therapeutic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Bipolar Disorder Therapeutic Market Report

Report Metric	Details
Report Name	Bipolar Disorder Therapeutic Market
Accounted market size in year	US$ 4012 million
Forecasted market size in 2031	US$ 4607 million
CAGR	2.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Antipsychotics Anticonvulsants Mood Stabilizers
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Allergan, Astellas Pharma, GlaxoSmithKline, Janssen Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bipolar Disorder Therapeutic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bipolar Disorder Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Bipolar Disorder Therapeutic Market growing?

Ans: The Bipolar Disorder Therapeutic Market witnessing a CAGR of 2.0% during the forecast period 2025-2031.

What is the Bipolar Disorder Therapeutic Market size in 2031?

Ans: The Bipolar Disorder Therapeutic Market size in 2031 will be US$ 4607 million.

Who are the main players in the Bipolar Disorder Therapeutic Market report?

Ans: The main players in the Bipolar Disorder Therapeutic Market are Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Allergan, Astellas Pharma, GlaxoSmithKline, Janssen Pharmaceuticals

What are the Application segmentation covered in the Bipolar Disorder Therapeutic Market report?

Ans: The Applications covered in the Bipolar Disorder Therapeutic Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Bipolar Disorder Therapeutic Market report?

Ans: The Types covered in the Bipolar Disorder Therapeutic Market report are Antipsychotics, Anticonvulsants, Mood Stabilizers

1 Bipolar Disorder Therapeutic Market Overview

1.1 Product Definition

1.2 Bipolar Disorder Therapeutic by Type

1.2.1 Global Bipolar Disorder Therapeutic Market Value Comparison by Type (2024 VS 2031)

1.2.2 Antipsychotics

1.2.3 Anticonvulsants

1.2.4 Mood Stabilizers

1.3 Bipolar Disorder Therapeutic by Application

1.3.1 Global Bipolar Disorder Therapeutic Market Value by Application (2024 VS 2031)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Bipolar Disorder Therapeutic Market Size Estimates and Forecasts

1.4.1 Global Bipolar Disorder Therapeutic Revenue 2020-2031

1.4.2 Global Bipolar Disorder Therapeutic Sales 2020-2031

1.4.3 Global Bipolar Disorder Therapeutic Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Bipolar Disorder Therapeutic Market Competition by Manufacturers

2.1 Global Bipolar Disorder Therapeutic Sales Market Share by Manufacturers (2020-2025)

2.2 Global Bipolar Disorder Therapeutic Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Bipolar Disorder Therapeutic Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Bipolar Disorder Therapeutic, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Bipolar Disorder Therapeutic, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Bipolar Disorder Therapeutic, Product Type & Application

2.7 Global Key Manufacturers of Bipolar Disorder Therapeutic, Date of Enter into This Industry

2.8 Global Bipolar Disorder Therapeutic Market Competitive Situation and Trends

2.8.1 Global Bipolar Disorder Therapeutic Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Bipolar Disorder Therapeutic Players Market Share by Revenue

2.8.3 Global Bipolar Disorder Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Bipolar Disorder Therapeutic Market Scenario by Region

3.1 Global Bipolar Disorder Therapeutic Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Bipolar Disorder Therapeutic Sales by Region: 2020-2031

3.2.1 Global Bipolar Disorder Therapeutic Sales by Region: 2020-2025

3.2.2 Global Bipolar Disorder Therapeutic Sales by Region: 2026-2031

3.3 Global Bipolar Disorder Therapeutic Revenue by Region: 2020-2031

3.3.1 Global Bipolar Disorder Therapeutic Revenue by Region: 2020-2025

3.3.2 Global Bipolar Disorder Therapeutic Revenue by Region: 2026-2031

3.4 North America Bipolar Disorder Therapeutic Market Facts & Figures by Country

3.4.1 North America Bipolar Disorder Therapeutic Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Bipolar Disorder Therapeutic Sales by Country (2020-2031)

3.4.3 North America Bipolar Disorder Therapeutic Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Bipolar Disorder Therapeutic Market Facts & Figures by Country

3.5.1 Europe Bipolar Disorder Therapeutic Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Bipolar Disorder Therapeutic Sales by Country (2020-2031)

3.5.3 Europe Bipolar Disorder Therapeutic Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Bipolar Disorder Therapeutic Market Facts & Figures by Region

3.6.1 Asia Pacific Bipolar Disorder Therapeutic Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Bipolar Disorder Therapeutic Sales by Region (2020-2031)

3.6.3 Asia Pacific Bipolar Disorder Therapeutic Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Bipolar Disorder Therapeutic Market Facts & Figures by Country

3.7.1 Latin America Bipolar Disorder Therapeutic Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Bipolar Disorder Therapeutic Sales by Country (2020-2031)

3.7.3 Latin America Bipolar Disorder Therapeutic Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Bipolar Disorder Therapeutic Market Facts & Figures by Country

3.8.1 Middle East and Africa Bipolar Disorder Therapeutic Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Bipolar Disorder Therapeutic Sales by Country (2020-2031)

3.8.3 Middle East and Africa Bipolar Disorder Therapeutic Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Bipolar Disorder Therapeutic Sales by Type (2020-2031)

4.1.1 Global Bipolar Disorder Therapeutic Sales by Type (2020-2025)

4.1.2 Global Bipolar Disorder Therapeutic Sales by Type (2026-2031)

4.1.3 Global Bipolar Disorder Therapeutic Sales Market Share by Type (2020-2031)

4.2 Global Bipolar Disorder Therapeutic Revenue by Type (2020-2031)

4.2.1 Global Bipolar Disorder Therapeutic Revenue by Type (2020-2025)

4.2.2 Global Bipolar Disorder Therapeutic Revenue by Type (2026-2031)

4.2.3 Global Bipolar Disorder Therapeutic Revenue Market Share by Type (2020-2031)

4.3 Global Bipolar Disorder Therapeutic Price by Type (2020-2031)

5 Segment by Application

5.1 Global Bipolar Disorder Therapeutic Sales by Application (2020-2031)

5.1.1 Global Bipolar Disorder Therapeutic Sales by Application (2020-2025)

5.1.2 Global Bipolar Disorder Therapeutic Sales by Application (2026-2031)

5.1.3 Global Bipolar Disorder Therapeutic Sales Market Share by Application (2020-2031)

5.2 Global Bipolar Disorder Therapeutic Revenue by Application (2020-2031)

5.2.1 Global Bipolar Disorder Therapeutic Revenue by Application (2020-2025)

5.2.2 Global Bipolar Disorder Therapeutic Revenue by Application (2026-2031)

5.2.3 Global Bipolar Disorder Therapeutic Revenue Market Share by Application (2020-2031)

5.3 Global Bipolar Disorder Therapeutic Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Eli Lilly

6.1.1 Eli Lilly Company Information

6.1.2 Eli Lilly Description and Business Overview

6.1.3 Eli Lilly Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Eli Lilly Bipolar Disorder Therapeutic Product Portfolio

6.1.5 Eli Lilly Recent Developments/Updates

6.2 Bristol-Myers Squibb

6.2.1 Bristol-Myers Squibb Company Information

6.2.2 Bristol-Myers Squibb Description and Business Overview

6.2.3 Bristol-Myers Squibb Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Bristol-Myers Squibb Bipolar Disorder Therapeutic Product Portfolio

6.2.5 Bristol-Myers Squibb Recent Developments/Updates

6.3 AstraZeneca

6.3.1 AstraZeneca Company Information

6.3.2 AstraZeneca Description and Business Overview

6.3.3 AstraZeneca Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2020-2025)

6.3.4 AstraZeneca Bipolar Disorder Therapeutic Product Portfolio

6.3.5 AstraZeneca Recent Developments/Updates

6.4 Allergan

6.4.1 Allergan Company Information

6.4.2 Allergan Description and Business Overview

6.4.3 Allergan Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Allergan Bipolar Disorder Therapeutic Product Portfolio

6.4.5 Allergan Recent Developments/Updates

6.5 Astellas Pharma

6.5.1 Astellas Pharma Company Information

6.5.2 Astellas Pharma Description and Business Overview

6.5.3 Astellas Pharma Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Astellas Pharma Bipolar Disorder Therapeutic Product Portfolio

6.5.5 Astellas Pharma Recent Developments/Updates

6.6 GlaxoSmithKline

6.6.1 GlaxoSmithKline Company Information

6.6.2 GlaxoSmithKline Description and Business Overview

6.6.3 GlaxoSmithKline Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2020-2025)

6.6.4 GlaxoSmithKline Bipolar Disorder Therapeutic Product Portfolio

6.6.5 GlaxoSmithKline Recent Developments/Updates

6.7 Janssen Pharmaceuticals

6.7.1 Janssen Pharmaceuticals Company Information

6.7.2 Janssen Pharmaceuticals Description and Business Overview

6.7.3 Janssen Pharmaceuticals Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Janssen Pharmaceuticals Bipolar Disorder Therapeutic Product Portfolio

6.7.5 Janssen Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Bipolar Disorder Therapeutic Industry Chain Analysis

7.2 Bipolar Disorder Therapeutic Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Bipolar Disorder Therapeutic Production Mode & Process Analysis

7.4 Bipolar Disorder Therapeutic Sales and Marketing

7.4.1 Bipolar Disorder Therapeutic Sales Channels

7.4.2 Bipolar Disorder Therapeutic Distributors

7.5 Bipolar Disorder Therapeutic Customer Analysis

8 Bipolar Disorder Therapeutic Market Dynamics

8.1 Bipolar Disorder Therapeutic Industry Trends

8.2 Bipolar Disorder Therapeutic Market Drivers

8.3 Bipolar Disorder Therapeutic Market Challenges

8.4 Bipolar Disorder Therapeutic Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Janssen Pharmaceuticals

List of Tables

Table 1. Global Bipolar Disorder Therapeutic Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Bipolar Disorder Therapeutic Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Bipolar Disorder Therapeutic Market Competitive Situation by Manufacturers in 2024

Table 4. Global Bipolar Disorder Therapeutic Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Bipolar Disorder Therapeutic Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Bipolar Disorder Therapeutic Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Bipolar Disorder Therapeutic Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Bipolar Disorder Therapeutic Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Bipolar Disorder Therapeutic, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Bipolar Disorder Therapeutic, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Bipolar Disorder Therapeutic, Product Type & Application

Table 12. Global Key Manufacturers of Bipolar Disorder Therapeutic, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Bipolar Disorder Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder Therapeutic as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Bipolar Disorder Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Bipolar Disorder Therapeutic Sales by Region (2020-2025) & (K Units)

Table 18. Global Bipolar Disorder Therapeutic Sales Market Share by Region (2020-2025)

Table 19. Global Bipolar Disorder Therapeutic Sales by Region (2026-2031) & (K Units)

Table 20. Global Bipolar Disorder Therapeutic Sales Market Share by Region (2026-2031)

Table 21. Global Bipolar Disorder Therapeutic Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Bipolar Disorder Therapeutic Revenue Market Share by Region (2020-2025)

Table 23. Global Bipolar Disorder Therapeutic Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Bipolar Disorder Therapeutic Revenue Market Share by Region (2026-2031)

Table 25. North America Bipolar Disorder Therapeutic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Bipolar Disorder Therapeutic Sales by Country (2020-2025) & (K Units)

Table 27. North America Bipolar Disorder Therapeutic Sales by Country (2026-2031) & (K Units)

Table 28. North America Bipolar Disorder Therapeutic Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Bipolar Disorder Therapeutic Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Bipolar Disorder Therapeutic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Bipolar Disorder Therapeutic Sales by Country (2020-2025) & (K Units)

Table 32. Europe Bipolar Disorder Therapeutic Sales by Country (2026-2031) & (K Units)

Table 33. Europe Bipolar Disorder Therapeutic Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Bipolar Disorder Therapeutic Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Bipolar Disorder Therapeutic Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Bipolar Disorder Therapeutic Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Bipolar Disorder Therapeutic Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Bipolar Disorder Therapeutic Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Bipolar Disorder Therapeutic Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Bipolar Disorder Therapeutic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Bipolar Disorder Therapeutic Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Bipolar Disorder Therapeutic Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Bipolar Disorder Therapeutic Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Bipolar Disorder Therapeutic Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Bipolar Disorder Therapeutic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Bipolar Disorder Therapeutic Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Bipolar Disorder Therapeutic Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Bipolar Disorder Therapeutic Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Bipolar Disorder Therapeutic Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Bipolar Disorder Therapeutic Sales (K Units) by Type (2020-2025)

Table 51. Global Bipolar Disorder Therapeutic Sales (K Units) by Type (2026-2031)

Table 52. Global Bipolar Disorder Therapeutic Sales Market Share by Type (2020-2025)

Table 53. Global Bipolar Disorder Therapeutic Sales Market Share by Type (2026-2031)

Table 54. Global Bipolar Disorder Therapeutic Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Bipolar Disorder Therapeutic Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Bipolar Disorder Therapeutic Revenue Market Share by Type (2020-2025)

Table 57. Global Bipolar Disorder Therapeutic Revenue Market Share by Type (2026-2031)

Table 58. Global Bipolar Disorder Therapeutic Price (USD/Unit) by Type (2020-2025)

Table 59. Global Bipolar Disorder Therapeutic Price (USD/Unit) by Type (2026-2031)

Table 60. Global Bipolar Disorder Therapeutic Sales (K Units) by Application (2020-2025)

Table 61. Global Bipolar Disorder Therapeutic Sales (K Units) by Application (2026-2031)

Table 62. Global Bipolar Disorder Therapeutic Sales Market Share by Application (2020-2025)

Table 63. Global Bipolar Disorder Therapeutic Sales Market Share by Application (2026-2031)

Table 64. Global Bipolar Disorder Therapeutic Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Bipolar Disorder Therapeutic Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Bipolar Disorder Therapeutic Revenue Market Share by Application (2020-2025)

Table 67. Global Bipolar Disorder Therapeutic Revenue Market Share by Application (2026-2031)

Table 68. Global Bipolar Disorder Therapeutic Price (USD/Unit) by Application (2020-2025)

Table 69. Global Bipolar Disorder Therapeutic Price (USD/Unit) by Application (2026-2031)

Table 70. Eli Lilly Company Information

Table 71. Eli Lilly Description and Business Overview

Table 72. Eli Lilly Bipolar Disorder Therapeutic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Eli Lilly Bipolar Disorder Therapeutic Product

Table 74. Eli Lilly Recent Developments/Updates

Table 75. Bristol-Myers Squibb Company Information

Table 76. Bristol-Myers Squibb Description and Business Overview

Table 77. Bristol-Myers Squibb Bipolar Disorder Therapeutic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Bristol-Myers Squibb Bipolar Disorder Therapeutic Product

Table 79. Bristol-Myers Squibb Recent Developments/Updates

Table 80. AstraZeneca Company Information

Table 81. AstraZeneca Description and Business Overview

Table 82. AstraZeneca Bipolar Disorder Therapeutic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. AstraZeneca Bipolar Disorder Therapeutic Product

Table 84. AstraZeneca Recent Developments/Updates

Table 85. Allergan Company Information

Table 86. Allergan Description and Business Overview

Table 87. Allergan Bipolar Disorder Therapeutic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Allergan Bipolar Disorder Therapeutic Product

Table 89. Allergan Recent Developments/Updates

Table 90. Astellas Pharma Company Information

Table 91. Astellas Pharma Description and Business Overview

Table 92. Astellas Pharma Bipolar Disorder Therapeutic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Astellas Pharma Bipolar Disorder Therapeutic Product

Table 94. Astellas Pharma Recent Developments/Updates

Table 95. GlaxoSmithKline Company Information

Table 96. GlaxoSmithKline Description and Business Overview

Table 97. GlaxoSmithKline Bipolar Disorder Therapeutic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. GlaxoSmithKline Bipolar Disorder Therapeutic Product

Table 99. GlaxoSmithKline Recent Developments/Updates

Table 100. Janssen Pharmaceuticals Company Information

Table 101. Janssen Pharmaceuticals Description and Business Overview

Table 102. Janssen Pharmaceuticals Bipolar Disorder Therapeutic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Janssen Pharmaceuticals Bipolar Disorder Therapeutic Product

Table 104. Janssen Pharmaceuticals Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Bipolar Disorder Therapeutic Distributors List

Table 108. Bipolar Disorder Therapeutic Customers List

Table 109. Bipolar Disorder Therapeutic Market Trends

Table 110. Bipolar Disorder Therapeutic Market Drivers

Table 111. Bipolar Disorder Therapeutic Market Challenges

Table 112. Bipolar Disorder Therapeutic Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Bipolar Disorder Therapeutic

Figure 2. Global Bipolar Disorder Therapeutic Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Bipolar Disorder Therapeutic Market Share by Type: 2024 & 2031

Figure 4. Antipsychotics Product Picture

Figure 5. Anticonvulsants Product Picture

Figure 6. Mood Stabilizers Product Picture

Figure 7. Global Bipolar Disorder Therapeutic Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Bipolar Disorder Therapeutic Market Share by Application: 2024 & 2031

Figure 9. Hospital Pharmacies

Figure 10. Retail Pharmacies

Figure 11. Online Pharmacies

Figure 12. Global Bipolar Disorder Therapeutic Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Bipolar Disorder Therapeutic Market Size (2020-2031) & (US$ Million)

Figure 14. Global Bipolar Disorder Therapeutic Sales (2020-2031) & (K Units)

Figure 15. Global Bipolar Disorder Therapeutic Average Price (USD/Unit) & (2020-2031)

Figure 16. Bipolar Disorder Therapeutic Report Years Considered

Figure 17. Bipolar Disorder Therapeutic Sales Share by Manufacturers in 2024

Figure 18. Global Bipolar Disorder Therapeutic Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Bipolar Disorder Therapeutic Players: Market Share by Revenue in Bipolar Disorder Therapeutic in 2024

Figure 20. Bipolar Disorder Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Bipolar Disorder Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Bipolar Disorder Therapeutic Sales Market Share by Country (2020-2031)

Figure 23. North America Bipolar Disorder Therapeutic Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Bipolar Disorder Therapeutic Sales Market Share by Country (2020-2031)

Figure 27. Europe Bipolar Disorder Therapeutic Revenue Market Share by Country (2020-2031)

Figure 28. Germany Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Bipolar Disorder Therapeutic Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Bipolar Disorder Therapeutic Revenue Market Share by Region (2020-2031)

Figure 35. China Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Bipolar Disorder Therapeutic Sales Market Share by Country (2020-2031)

Figure 46. Latin America Bipolar Disorder Therapeutic Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Bipolar Disorder Therapeutic Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Bipolar Disorder Therapeutic Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. U.A.E Bipolar Disorder Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Bipolar Disorder Therapeutic by Type (2020-2031)

Figure 56. Global Revenue Market Share of Bipolar Disorder Therapeutic by Type (2020-2031)

Figure 57. Global Bipolar Disorder Therapeutic Price (USD/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Bipolar Disorder Therapeutic by Application (2020-2031)

Figure 59. Global Revenue Market Share of Bipolar Disorder Therapeutic by Application (2020-2031)

Figure 60. Global Bipolar Disorder Therapeutic Price (USD/Unit) by Application (2020-2031)

Figure 61. Bipolar Disorder Therapeutic Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-9K13584

Mon Sep 15 00:00:00 UTC 2025

Add to Cart

Global Depressive Disorder Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Z6361

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Major Depressive Disorder (MDD) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9N6266

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Major Depressive Disorder Therapeutic Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19F13948

Fri Sep 05 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Bipolar Disorder Therapeutic Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-22P13573

Global Bipolar Disorder Therapeutic Market Research Report 2025

FEATURED COMPANIES

Bipolar Disorder Therapeutic Market Size

Bipolar Disorder Therapeutic Market

Report Scope

Scope of Bipolar Disorder Therapeutic Market Report

Core Chapters

FAQ for this report

How fast is Bipolar Disorder Therapeutic Market growing?

What is the Bipolar Disorder Therapeutic Market size in 2031?

Who are the main players in the Bipolar Disorder Therapeutic Market report?

What are the Application segmentation covered in the Bipolar Disorder Therapeutic Market report?

What are the Type segmentation covered in the Bipolar Disorder Therapeutic Market report?

FEATURED COMPANIES

RELATED REPORTS